Rothschild Investment Corp IL raised its holdings in shares of Monsanto (NYSE:MON) by 0.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,112 shares of the basic materials company’s stock after purchasing an additional 510 shares during the quarter. Rothschild Investment Corp IL’s holdings in Monsanto were worth $6,903,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Janus Henderson Group PLC lifted its holdings in shares of Monsanto by 2,540.4% during the second quarter. Janus Henderson Group PLC now owns 1,491,324 shares of the basic materials company’s stock worth $176,515,000 after buying an additional 1,434,844 shares in the last quarter. Harding Loevner LP lifted its holdings in shares of Monsanto by 140.0% during the third quarter. Harding Loevner LP now owns 2,294,152 shares of the basic materials company’s stock worth $111,903,000 after buying an additional 1,338,271 shares in the last quarter. Capital International Investors lifted its holdings in shares of Monsanto by 10.3% during the third quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock worth $1,119,650,000 after buying an additional 872,377 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after buying an additional 784,418 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Monsanto by 75.1% during the fourth quarter. Bank of Montreal Can now owns 1,043,409 shares of the basic materials company’s stock worth $121,850,000 after buying an additional 447,662 shares in the last quarter. 75.41% of the stock is owned by institutional investors and hedge funds.
In related news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.70% of the stock is owned by insiders.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm’s revenue for the quarter was up .3% compared to the same quarter last year. During the same period last year, the firm earned $0.21 EPS. analysts anticipate that Monsanto will post 5.76 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date is Thursday, January 4th. Monsanto’s dividend payout ratio (DPR) is presently 39.93%.
A number of research firms have recently weighed in on MON. Wells Fargo & Co reissued a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Barclays reissued an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reissued a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Thursday, October 5th. Finally, Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Monsanto has an average rating of “Hold” and a consensus price target of $127.30.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.